New drug selonabant put to the test in healthy volunteers
Knowledge-focused
Completed
This early-stage study tested a single dose of the drug selonabant in 40 healthy adults aged 18 to 30. The main goal was to check for side effects and see how the body processes the drug. Participants received either the drug or a placebo, and researchers monitored their health c…
Phase: PHASE1 • Sponsor: Anebulo Pharmaceuticals • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC